Document is current
Any future updates will be listed below
-
Authors
Likhvantsev, Valery V.
Landoni, Giovanni
Bagdasarov, Pavel S.
Berikashvili, Levan B.
Kadantseva, Kristina K.
Subbotin, Valerii V.
Khalikova, Elena Yu.
Shemetova, Maria M.
Yadgarov, Mikhail Ya.
Polyakov, Petr A.
Aliev, Vladimir A.
Malakhova, Anna
Zaraca, Luisa
Nogtev, Pavel V.
Smirnova, Anastasia V.
Alyaeva, Dayana N.
Yavorovskaya, Daria A.
Lamacchia, Andrea
Gallo, Lorenzo
De Vecchi, Jessica
Yavorovsky, Andrey G.
Grechko, Andrey V.
- License Information
-
More Information
Article History
Received: 18 December 2025
Accepted: 8 February 2026
First Online: 16 February 2026
Declarations
:
: The protocol and all amendments were approved before enrolment by the Ethics Committee of I.M. Sechenov First Moscow State Medical University (protocol No. 01–21); the Ethics Committee of A. Loginov Moscow Clinical Scientific Center (protocol No. 20/10/22); and the Ethics Committee of the Moscow State Budgetary Healthcare Institution “Oncological Center No. 1 of Moscow City Hospital named after S.S. Yudin, Moscow Healthcare Department” (protocol No. 1/22/3). The trial adhered to the Declaration of Helsinki and ICH-GCP. Written informed consent was obtained from all participants before any study procedures.
: Not applicable.
: The authors declare that they have no competing interests.
